NASDAQ:AMIX Autonomix Medical Q1 2026 Earnings Report $2.70 -0.09 (-3.08%) As of 12:08 PM Eastern This is a fair market value price provided by Massive. Learn more. ProfileEarnings HistoryForecast Autonomix Medical EPS ResultsActual EPS-$22.47Consensus EPS -$20.58Beat/MissMissed by -$1.89One Year Ago EPSN/AAutonomix Medical Revenue ResultsActual RevenueN/AExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AAutonomix Medical Announcement DetailsQuarterQ1 2026Date8/13/2025TimeBefore Market OpensConference Call DateWednesday, August 13, 2025Conference Call Time7:00AM ETUpcoming EarningsAutonomix Medical's Q1 2027 earnings is estimated for Wednesday, August 12, 2026, based on past reporting schedules, with a conference call scheduled on Friday, August 14, 2026 at 4:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Conference Call ResourcesQuarterly Report (10-Q)Earnings HistoryCompany ProfilePowered by Earnings DocumentsQuarterly report(10-Q) Autonomix Medical Earnings HeadlinesAutonomix Medical Reports Preclinical Study Shows Neural Sensing Platform Can Detect and Localize Renal Nerve ActivityJuly 24, 2026 | quiverquant.comQAutonomix Medical Demonstrates Renal Nerve Sensing and Neural Activity Change in Preclinical StudyJuly 24, 2026 | globenewswire.comThe $8,000 Gold Call Every Retirement Saver Needs to Read Right NowGold didn't creep higher—it broke $5,000, a level many analysts thought would hold. Now JPMorgan, the biggest bank on earth, just raised its 2026 gold forecast to $6,300 and laid out a credible path to $8,000 if everyday investors increase their gold allocations even slightly. Most Americans hold less than 1% in gold, and if that number moves even slightly higher, demand collides with limited supply, and prices reprice fast.July 28 at 1:00 AM | Golden Crest Metals (Ad)Autonomix Medical Secures New U.S. Patent Strengthening Next-Generation Precision Neuromodulation PlatformJuly 23, 2026 | globenewswire.comAutonomix Medical (NASDAQ:AMIX) Stock Price Up 1.4% - Here's WhyJuly 22, 2026 | americanbankingnews.comAutonomix Medical Receives U.S. Patent Expanding Neural Sensing Platform into Overactive Bladder Urology MarketJuly 15, 2026 | quiverquant.comQSee More Autonomix Medical Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Autonomix Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Autonomix Medical and other key companies, straight to your email. Email Address About Autonomix MedicalAutonomix Medical (NASDAQ:AMIX), a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.View Autonomix Medical ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Amkor Sells Off After Earnings—Why Weak Guidance Isn't the Real StoryIs the Market Mispricing ServiceNow's AI Future?Whirlpool’s Report May Show How Frozen the Housing Market Really IsAMD’s AI Bubble Could Burst Into Explosive UpsideRefiner Stocks Are Near Record Highs—Can Iran-Driven Margins Keep Them There?Atlassian’s AI Pivot Is Starting to Challenge Wall Street’s Bear CaseVerizon May Be an AI Infrastructure Stock Hiding in Plain Sight Upcoming Earnings Agnico Eagle Mines (7/29/2026)General Dynamics (7/29/2026)L3Harris Technologies (7/29/2026)Automatic Data Processing (7/29/2026)Amphenol (7/29/2026)ARM (7/29/2026)Fortinet (7/29/2026)Lam Research (7/29/2026)Meta Platforms (7/29/2026)Microsoft (7/29/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
